TMS Co., Ltd. (JP:4891) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TMS Co., Ltd. has secured a U.S. patent for a new treatment for acute kidney injury using compounds including TMS-008, further strengthening its global intellectual property portfolio alongside recent grants in Japan and China. This development highlights TMS’s commitment to advancing innovative treatments in areas with high unmet medical needs.
For further insights into JP:4891 stock, check out TipRanks’ Stock Analysis page.